Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Cells of the human intestinal tract mapped across space and time

Elmentaite R. et al, (2021), Nature, 597, 250 - 255

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Mlcochova P. et al, (2021), Nature

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

Wei J. et al, (2021), Nature Microbiology, 6, 1140 - 1149

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017.

Kamau E. et al, (2021), Emerging infectious diseases, 27, 2261 - 2268

Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Pouwels KB. et al, (2021)

An end-to-end heterogeneous graph attention network for Mycobacterium tuberculosis drug-resistance prediction.

Yang Y. et al, (2021), Briefings in bioinformatics

Biallelic PI4KA variants cause neurological, intestinal and immunological disease.

Salter CG. et al, (2021), Brain : a journal of neurology

From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil driven diseases

Pavord ID. et al, (2021), Allergy

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.

Skelly DT. et al, (2021), Nature communications, 12

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.

Bafadhel M. et al, (2021), Eur Respir J

The development of an intervention to support uptake and adherence to antiretroviral therapy in people living with HIV: the SUPA intervention. A brief report

King K. et al, (2021), Translational Behavioral Medicine

Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction.

Lamikanra A. et al, (2021), Transfusion

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Lumley SF. et al, (2021), Clinical Infectious Diseases, 73, e699 - e709

Generalizable characteristics of false-positive bacterial variant calls.

Bush SJ., (2021), Microbial genomics, 7

Genomic network analysis of environmental and livestock F-type plasmid populations

Matlock W. et al, (2021), The ISME Journal, 15, 2322 - 2335

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations

Mokaya J. et al, (2021), Journal of Viral Hepatitis, 28, 1110 - 1120

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.

Pritchard E. et al, (2021), Nature medicine, 27, 1370 - 1378

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Yu L-M. et al, (2021), The Lancet

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485

Therapeutic vaccination for treatment of chronic hepatitis B.

Cargill T. and Barnes E., (2021), Clinical and experimental immunology, 205, 106 - 118

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?